Ipamorelin was developed by Novo Nordisk as a selective GHS-R1a agonist designed to stimulate GH release without significant cortisol or prolactin responses, in contrast to earlier ghrelin-receptor agonists such as GHRP-6 and GHRP-2
In immunocompromised pregnancies that have rendered pregnancy complications, a supraphysiological dosage of melatonin has been shown to reverse the adverse effects of these complications for both the mother and the fetus (34, 86)
Because formal, large-scale Phase 3 clinical trials for Long COVID are still scaling up, researchers have relied heavily on massive patient-reported outcome surveys to see what is working in real-world clinical settings
In a 2017 review, it was noted that this peptide has reduced the appearance of wrinkles by around 12% (11.64% to be exact) in human subjects
Kobayashi A, Kang M-I, Okawa H, Ohtsuji M, Zenke Y, Chiba T, et al